(Q35556040)

8 August 2017

title

Treatment continuation in patients receiving biological agents or conventional DMARD therapy (English)

1 reference

8 August 2017

Zink A

1

1 reference

8 August 2017

Listing J

2

1 reference

8 August 2017

Kary S

3

1 reference

8 August 2017

Ramlau P

4

1 reference

8 August 2017

Stoyanova-Scholz M

5

1 reference

8 August 2017

Babinsky K

6

1 reference

8 August 2017

von Hinueber U

7

1 reference

8 August 2017

Gromnica-Ihle E

8

1 reference

8 August 2017

Wassenberg S

9

1 reference

8 August 2017

Antoni C

10

1 reference

8 August 2017

Herzer P

11

1 reference

8 August 2017

Kekow J

12

1 reference

8 August 2017

Schneider M

13

1 reference

8 August 2017

Rau R

14

1 reference

8 August 2017

language of work or name

English

0 references

publication date

11 February 2005

1 reference

Annals of the Rheumatic Diseases

8 August 2017

published in

1 reference

8 August 2017

volume

64

1 reference

8 August 2017

issue

9

1 reference

8 August 2017

page(s)

1274-1279

1 reference

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755655

Efficacy and safety of leflunomide and predisposing factors for treatment response in patients with active rheumatoid arthritis: RELIEF 6-month data.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755655

Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755655

Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755655

Survival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755655

Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755655

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755655

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755655

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755655

Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755655

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15708884

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15708884

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Comparative evaluation of a German version of the Health Assessment Questionnaire and the Hannover Functional Capacity Questionnaire]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15708884

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ARD.2004.031476

1 reference

8 August 2017

1 reference

8 August 2017

1 reference